文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

住院老年呼吸道合胞病毒感染患者的急性心脏事件

Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection.
PubMed 文献 · JAMA Intern Med · 2024-01-01
一句话结论50岁及以上RSV住院成人中约22.4%发生急性心脏事件,以急性心衰最常见,合并心脏事件者ICU入住与院内死亡风险更高。

该横断面研究分析RSV住院监测网络12个州、5个RSV季节(2014-2015至2017-2018及2022-2023)的6248例50岁及以上RSV住院成人(中位年龄72.7岁,59.6%女性,56.4%有基础心血管病)。加权估计急性心脏事件发生率为22.4%,其中心衰15.8%、急性缺血性心脏病7.5%。有基础心血管病者发生心脏事件风险显著高于无基础心血管病者(33.0% vs 8.5%;ARR 3.51)。发生心脏事件者ICU入住(25.8% vs 16.5%;ARR 1.54)与院内死亡(8.1% vs 4.0%;ARR 1.77)风险均高于无心脏事件者。

要点

  • 50岁及以上RSV住院成人急性心脏事件加权发生率为22.4%(95%CI 21.0%-23.7%),最常见为急性心衰15.8%(95%CI 14.6%-17.0%)。
  • 即使无基础心血管病记录者,急性心脏事件发生率仍达8.5%(约1/12),不能因无心脏病史而忽视心脏并发症。
  • 有基础心血管病者发生急性心脏事件的风险显著高于无基础心血管病者(33.0% vs 8.5%;ARR 3.51;95%CI 2.85-4.32)。
  • 发生急性心脏事件者ICU入住率25.8% vs 16.5%(ARR 1.54;95%CI 1.23-1.93),院内死亡率8.1% vs 4.0%(ARR 1.77;95%CI 1.36-2.31)。
  • 全部RSV住院成人中18.6%需ICU入住、4.9%院内死亡。

适用人群与场景

  • 50岁及以上、实验室确诊RSV感染的住院成人(中位年龄72.7岁,59.6%女性,56.4%有基础心血管病)。
  • 数据来自12个州、5个RSV季节(2014-2015至2017-2018及2022-2023)经临床医生导向实验室检测发现的住院病例。

诊断标准与关键阈值

  • 急性心脏事件依据国际疾病分类第9版临床修订版(ICD-9-CM)或国际疾病统计分类第10版临床修订版(ICD-10-CM)出院编码及出院小结复核识别。

研究设计与关键结果

  • 横断面研究,纳入6248例50岁及以上实验室确诊RSV住院成人,来自RSV住院监测网络12个州、5个RSV季节。
  • 加权估计任何急性心脏事件发生率为22.4%(95%CI 21.0%-23.7%)。
  • 急性心衰加权发生率15.8%(95%CI 14.6%-17.0%),急性缺血性心脏病7.5%(95%CI 6.8%-8.3%),高血压危象1.3%(95%CI 1.0%-1.7%),室性心动过速1.1%(95%CI 0.8%-1.4%),心源性休克0.6%(95%CI 0.4%-0.8%)。
  • 有基础心血管病者发生急性心脏事件的风险高于无基础心血管病者(33.0% vs 8.5%;ARR 3.51;95%CI 2.85-4.32)。
  • 全部住院RSV成人中18.6%需ICU入住、4.9%院内死亡。
  • 发生急性心脏事件者较未发生者ICU入住率更高(25.8% vs 16.5%;ARR 1.54;95%CI 1.23-1.93),院内死亡率更高(8.1% vs 4.0%;ARR 1.77;95%CI 1.36-2.31)。

证据类型、等级与局限

  • 证据类型:横断面研究,分析RSV住院监测网络的监测数据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现阐明了RSV疫苗上市前RSV感染潜在心脏并发症的基线流行病学。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Respiratory syncytial virus (RSV) infection can cause severe respiratory illness in older adults. Less is known about the cardiac complications of RSV disease compared with those of influenza and SARS-CoV-2 infection.

OBJECTIVE: To describe the prevalence and severity of acute cardiac events during hospitalizations among adults aged 50 years or older with RSV infection.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed surveillance data from the RSV Hospitalization Surveillance Network, which conducts detailed medical record abstraction among hospitalized patients with RSV infection detected through clinician-directed laboratory testing. Cases of RSV infection in adults aged 50 years or older within 12 states over 5 RSV seasons (annually from 2014-2015 through 2017-2018 and 2022-2023) were examined to estimate the weighted period prevalence and 95% CIs of acute cardiac events.

EXPOSURES: Acute cardiac events, identified by International Classification of Diseases, 9th Revision, Clinical Modification or International Statistical Classification of Diseases, Tenth Revision, Clinical Modification discharge codes, and discharge summary review.

MAIN OUTCOMES AND MEASURES: Severe disease outcomes, including intensive care unit (ICU) admission, receipt of invasive mechanical ventilation, or in-hospital death. Adjusted risk ratios (ARR) were calculated to compare severe outcomes among patients with and without acute cardiac events.

RESULTS: The study included 6248 hospitalized adults (median [IQR] age, 72.7 [63.0-82.3] years; 59.6% female; 56.4% with underlying cardiovascular disease) with laboratory-confirmed RSV infection. The weighted estimated prevalence of experiencing a cardiac event was 22.4% (95% CI, 21.0%-23.7%). The weighted estimated prevalence was 15.8% (95% CI, 14.6%-17.0%) for acute heart failure, 7.5% (95% CI, 6.8%-8.3%) for acute ischemic heart disease, 1.3% (95% CI, 1.0%-1.7%) for hypertensive crisis, 1.1% (95% CI, 0.8%-1.4%) for ventricular tachycardia, and 0.6% (95% CI, 0.4%-0.8%) for cardiogenic shock. Adults with underlying cardiovascular disease had a greater risk of experiencing an acute cardiac event relative to those who did not (33.0% vs 8.5%; ARR, 3.51; 95% CI, 2.85-4.32). Among all hospitalized adults with RSV infection, 18.6% required ICU admission and 4.9% died during hospitalization. Compared with patients without an acute cardiac event, those who experienced an acute cardiac event had a greater risk of ICU admission (25.8% vs 16.5%; ARR, 1.54; 95% CI, 1.23-1.93) and in-hospital death (8.1% vs 4.0%; ARR, 1.77; 95% CI, 1.36-2.31).

CONCLUSIONS AND RELEVANCE: In this cross-sectional study over 5 RSV seasons, nearly one-quarter of hospitalized adults aged 50 years or older with RSV infection experienced an acute cardiac event (most frequently acute heart failure), including 1 in 12 adults (8.5%) with no documented underlying cardiovascular disease. The risk of severe outcomes was nearly twice as high in patients with acute cardiac events compared with patients who did not experience an acute cardiac event. These findings clarify the baseline epidemiology of potential cardiac complications of RSV infection prior to RSV vaccine availability.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Woodruff RC, Melgar M, Pham H, et al. Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection. JAMA Intern Med. 2024. PMID: 38619857. doi:10.1001/jamainternmed.2024.0212

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。